Loading…
Lobbying Spend
—
Filings
93
Firms Hired
3
Active Period
2009–2023
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Revoke Iranian Funding Act of 2023
2023 · first_quarter · Firm: HOLLAND & KNIGHT LLP
Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Revoke Iranian Funding Act of 2023
2023 · first_quarter · Firm: HOLLAND & KNIGHT LLP
Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer research, including community health funding and capital funding for cancer centers; pharmacogenic issues related to H.R. 6000 - CURES 2.0; collaboration with the Department of Veterans Affairs.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer research, including community health funding and capital funding for cancer centers; pharmacogenic issues related to H.R. 6000 - CURES 2.0; collaboration with the Department of Veterans Affairs.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer research, including community health funding and capital funding for cancer centers; pharmacogenic issues related to H.R. 6000 - CURES 2.0; collaboration with the Department of Veterans Affairs.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Funding for cancer research, including community health funding and capital funding for cancer centers; pharmacogenic issues related to H.R. 6000 - CURES 2.0; collaboration with the Department of Veterans Affairs.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6000
Veteran's Prostate Cancer Treatment and Research Act
2020 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES
H.R.7609, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division F -- Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020, Cancer research and development implementation issues Public Law 116-260, Consolidated Appropriations Act, 2021, Division J, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021, Cancer research and development issues Monitor H.R.6092, Veteran's Prostate Cancer Treatment and Research Act, generally
Client expense: — · Firm income: $20,000
Matched citations: H.R.6092
Monitor Provider payment related issues: Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Public Law 116-260, Consolidated Appropriations Act, 2021, Division M, Coronavirus Response and Relief Supplemental Appropriations Act, FY2021; and Division N, Additional Coronavirus Response Relief
Client expense: — · Firm income: $20,000
Matched citations: H.R.6800
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer clinical trial research issues Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Cancer clinical trial research issues Monitor Healthcare issues, generally as follows: H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Public Law 116-136, Coronavirus Aid, Relief, and Economic Security Act, Healthcare related issues Public Law 116-260, Consolidated Appropriations Act, 2021, Division M, Coronavirus Response and Relief Supplemental Appropriations Act, 2021, Division N, Additional Coronavirus Response Relief
Client expense: — · Firm income: $20,000
Matched citations: H.R.6800
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021
2020 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES
H.R.7609, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division F -- Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020, Cancer research and development implementation issues Public Law 116-260, Consolidated Appropriations Act, 2021, Division J, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021, Cancer research and development issues Monitor H.R.6092, Veteran's Prostate Cancer Treatment and Research Act, generally
Client expense: — · Firm income: $20,000
Matched citations: H.R.7609
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021
2020 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer clinical trial research issues H.R.7609, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division F -- Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020, Cancer research and development implementation issues Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Cancer clinical trial research issues; and Division J, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues
Client expense: — · Firm income: $20,000
Matched citations: H.R.7609
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
2020 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer clinical trial research issues Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Cancer clinical trial research issues Monitor Healthcare issues, generally as follows: H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Public Law 116-136, Coronavirus Aid, Relief, and Economic Security Act, Healthcare related issues Public Law 116-260, Consolidated Appropriations Act, 2021, Division M, Coronavirus Response and Relief Supplemental Appropriations Act, 2021, Division N, Additional Coronavirus Response Relief
Client expense: — · Firm income: $20,000
Matched citations: H.R.7614
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
2020 · fourth_quarter · Firm: VAN SCOYOC ASSOCIATES
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer clinical trial research issues H.R.7609, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division F -- Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020, Cancer research and development implementation issues Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Cancer clinical trial research issues; and Division J, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues
Client expense: — · Firm income: $20,000
Matched citations: H.R.7614
Veteran's Prostate Cancer Treatment and Research Act
2020 · third_quarter · Firm: VAN SCOYOC ASSOCIATES
Monitor the following: H.R.7609, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division F -- Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020, Cancer research and development implementation issues H.R.6092, Veteran's Prostate Cancer Treatment and Research Act, generally
Client expense: — · Firm income: $10,000
Matched citations: H.R.6092
Monitor Provider payment related issues: Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Future COVID-19 legislaiton
Client expense: — · Firm income: $10,000
Matched citations: H.R.6800
Monitor the following: Cancer research and development, and therapy related issues Public Law 116-136, Coronavirus Aid, Relief, and Economic Security Act, Healthcare related issues H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer clinical trial research issues Monitor Healthcare issues, generally as follows: H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Future COVID-19 legislation
Client expense: — · Firm income: $10,000
Matched citations: H.R.6800
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021
2020 · third_quarter · Firm: VAN SCOYOC ASSOCIATES
Monitor the following: H.R.7609, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division F -- Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020, Cancer research and development implementation issues H.R.6092, Veteran's Prostate Cancer Treatment and Research Act, generally
Client expense: — · Firm income: $10,000
Matched citations: H.R.7609
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021
2020 · third_quarter · Firm: VAN SCOYOC ASSOCIATES
Monitor the following: H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer clinical trial research issues H.R.7609, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2021, Cancer research and development issues Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division F -- Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2020, Cancer research and development implementation issues
Client expense: — · Firm income: $10,000
Matched citations: H.R.7609
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
2020 · third_quarter · Firm: VAN SCOYOC ASSOCIATES
Monitor the following: Cancer research and development, and therapy related issues Public Law 116-136, Coronavirus Aid, Relief, and Economic Security Act, Healthcare related issues H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Cancer clinical trial research issues Monitor Healthcare issues, generally as follows: H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Future COVID-19 legislation
Client expense: — · Firm income: $10,000
Matched citations: H.R.7614
Source: Senate LDA